During the past decade, Woj. Wielospec. Centrum Onkologii i Traumatologii conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Woj. Wielospec. Centrum Onkologii i Traumatologii" are "Chronic Lymphocytic Leukemia" (1 trials), "Metastatic Prostate Cancer" (1 trials), "NSCLC" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Woj. Wielospec. Centrum Onkologii i Traumatologii" in a lesser frequency.

Most popular intervention types in "Woj. Wielospec. Centrum Onkologii i Traumatologii" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abiraterone" (1 trials), "Atezolizumab" (1 trials), "Bendamustine" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Woj. Wielospec. Centrum Onkologii i Traumatologii" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Woj. Wielospec. Centrum Onkologii i Traumatologii". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Woj. Wielospec. Centrum Onkologii i Traumatologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Woj. Wielospec. Centrum Onkologii i Traumatologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".